We provide the latest news
from the world of economics and finance
(RTTNews) - Evolent Health (EVH) has entered into an agreement to acquire certain assets of Machinify and the royalty-free license of Machinify Auth, a software platform that leverages the latest advances in artificial intelligence to increase the clinical quality, speed and consistency of the clinical reviews for all specialty conditions. Machinify is a privately held company based in Palo Alto, California.
Evolent plans to integrate the Machinify Auth team, software applications and AI capabilities into its platform. Evolent and Machinify will also enter into a multi-year services agreement. Evolent Health said the acquisition is immaterial to revenue outlook and estimates to be neutral to Adjusted EBITDA in the first year after closing.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.